Zoetis will acquire Neogen’s animal genomics business for $160 million, strengthening its Precision Animal Health capabilities across livestock and companion animals worldwide.
New data from the AVMA’s 2025 Pet Ownership and Demographic Sourcebook show most U.S. pet owners are highly satisfied with their veterinary practice, particularly in areas of staff friendliness, knowledge, and quality of care.
Authorization allows veterinarians to use NexGard® and NexGard® COMBO to treat New World screwworm infestations amid spread in Mexico.
Merck Animal Health has received FDA approval for NUMELVI™ (atinvicitinib tablets), the first and only second-generation JAK inhibitor indicated for control of pruritus associated with allergic dermatitis in dogs six months of age and older.
The global animal parasiticides market is projected to grow from $12.98 billion in 2026 to $17.50 billion by 2031, fueled by companion animal demand, long-acting formulations, and AI-enabled parasite management technologies.
epiq Animal Health has entered a strategic distribution agreement with Mars Petcare US that expands access to GREENIES™ Dental Treats and Pill Pockets across the animal health industry.
Chewy announced plans to acquire SmartEquine (formerly SmartPak Equine) from Covetrus, expanding its footprint in the equine health category and strengthening its recurring revenue base.
Zoetis has launched the first commercial genetic predictions for bovine respiratory disease, giving beef producers new tools to select cattle with stronger genetic potential for health, survival, and profitability.
Vytelle outlined a series of 2025 platform enhancements aimed at improving IVF efficiency, genetic decision-making, and sustainability measurement for beef producers worldwide.
Apr 9–Apr 12, 2026 | Boston, MA
Apr 16–Apr 18, 2026 | Washington, DC
Apr 30–May 3, 2026 | Indianapolis, IN
Jun 10–Jun 13, 2026 | Seattle
Jun 16–Jun 19, 2026 | Ho Chi Minh City
Zoetis will acquire Neogen’s animal genomics business for $160 million, strengthening its Precision Animal Health capabilities across livestock and companion animals worldwide.
Zoetis will participate in the Bank of America Securities 2026 Animal Health Summit on February 26, with CFO Wetteny Joseph representing the company.
Tartar Shield has launched the “Second Smile” initiative, providing preventive dental care and professional adoption photography for more than 120 shelter dogs in partnership with Second Shot and the Humane Society of Tampa Bay.
Authorization allows veterinarians to use NexGard® and NexGard® COMBO to treat New World screwworm infestations amid spread in Mexico.
Merck Animal Health has received FDA approval for NUMELVI™ (atinvicitinib tablets), the first and only second-generation JAK inhibitor indicated for control of pruritus associated with allergic dermatitis in dogs six months of age and older.
The U.S. FDA has granted an Emergency Use Authorization for IVOMEC® (ivermectin) 1% Injection, marking the first over-the-counter product authorized to help prevent New World screwworm infestations in cattle amid heightened regional surveillance concerns.
The FDA has conditionally approved Anivive’s Laverdia-CA1 (verdinexor), the first oral SINE-based therapy designed for canine lymphoma, expanding at-home treatment options for both B-cell and T-cell disease.
